HISTIOCYTIC NEOPLASMS
Clinical trials for HISTIOCYTIC NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new HISTIOCYTIC NEOPLASMS trials appear
Sign up with your email to follow new studies for HISTIOCYTIC NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could this pill tame rare immune tumors?
Disease control Recruiting nowThis study tests a drug called ulixertinib for people with histiocytic neoplasms, a rare group of disorders where immune cells form tumors. The drug is taken as a pill twice daily. Researchers want to see if it can shrink tumors and control the disease. The trial will enroll 38 a…
Matched conditions: HISTIOCYTIC NEOPLASMS
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New PET tracer could spot Hard-to-See cancers
Knowledge-focused Recruiting nowThis early-phase study is testing a new imaging agent called [68Ga]-pentixafor to see how well it shows up on PET/CT scans in people with certain blood cancers (like multiple myeloma and non-Hodgkin lymphoma) and rare immune cell tumors. About 30 participants will get the agent a…
Matched conditions: HISTIOCYTIC NEOPLASMS
Phase: EARLY_PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC